LAVRA, Luca
 Distribuzione geografica
Continente #
NA - Nord America 1.394
EU - Europa 485
AS - Asia 285
SA - Sud America 20
OC - Oceania 1
Totale 2.185
Nazione #
US - Stati Uniti d'America 1.382
IT - Italia 129
SG - Singapore 114
UA - Ucraina 87
IN - India 83
SE - Svezia 74
CN - Cina 68
FI - Finlandia 52
IE - Irlanda 47
DE - Germania 27
AR - Argentina 20
FR - Francia 17
GB - Regno Unito 16
BG - Bulgaria 14
CA - Canada 10
IR - Iran 10
ID - Indonesia 6
RO - Romania 5
RU - Federazione Russa 5
NL - Olanda 4
BE - Belgio 3
GR - Grecia 2
IL - Israele 2
MX - Messico 2
AU - Australia 1
KR - Corea 1
LV - Lettonia 1
MK - Macedonia 1
PL - Polonia 1
VN - Vietnam 1
Totale 2.185
Città #
Chandler 197
Fairfield 174
Ashburn 87
Singapore 86
Woodbridge 80
Houston 74
Rome 73
Seattle 60
Cambridge 59
Princeton 55
Ann Arbor 48
Dublin 47
Santa Clara 47
Wilmington 47
Plano 42
Beijing 37
Dearborn 35
Jacksonville 32
Millbury 26
Des Moines 24
Federal 19
Andover 18
Boston 16
San Paolo di Civitate 16
Sofia 14
Helsinki 12
Lawrence 11
New York 9
San Diego 8
Boardman 7
London 7
Jakarta 6
Toronto 6
Bühl 5
Falls Church 5
Mannheim 4
Norwalk 4
Redmond 4
San Mateo 4
Amsterdam 3
Bremen 3
Brussels 3
Catania 3
Kunming 3
Phoenix 3
Stockholm 3
Falkenstein 2
Guangzhou 2
Hyderabad 2
Laurel 2
Milan 2
Nanchang 2
Nanjing 2
North York 2
Royal Leamington Spa 2
Viareggio 2
Atlanta 1
Bacoli 1
Baoding 1
Baotou 1
Berlin 1
Bologna 1
Buenos Aires 1
Buffalo 1
Changsha 1
Codroipo 1
Coominya 1
Corsico 1
Fort Worth 1
Frankfurt am Main 1
Frosinone 1
Gunzenhausen 1
Harbin 1
Hefei 1
Ho Chi Minh City 1
Huzhou 1
Jinan 1
Leipzig 1
Livorno 1
Los Angeles 1
Montclair 1
Montréal 1
Moscow 1
Nanning 1
Ningbo 1
Ottawa 1
Palo Del Colle 1
Portland 1
Provo 1
Quzhou 1
Redwood City 1
Riga 1
Sacramento 1
San Francisco 1
Scuola 1
Seoul 1
Shanghai 1
Shijiazhuang 1
Skopje 1
Staten Island 1
Totale 1.590
Nome #
Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA cytology. 103
Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules 95
Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3. 90
Galectin-3. One molecule for an alphabet of diseases, from A to Z 90
Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium 88
Valutazione del ruolo prognostico dei sottotipi istologici nei carcinomi papilliferi della tiroide con particolare riferimento della variante in sclerosi diffusa. 87
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology 84
Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. 80
Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis 80
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness 79
The loss of the p53 activator HIPK2 is responsible for Galectin-3 overexpression in well differentiated thyroid carcinomas 79
Antiproliferative effects of 1α-OH-vitD 3 in malignant melanoma: potential therapeutic implications 79
The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas 68
Analysis of the role of p53 and Galectin-3 in proliferation and apoptosis of thyroid carcinoma cell lines by specific RNA interference experiments 66
Investigation of VOCs associated with different characteristics of breast cancer cells 62
IDENTIFICAZIONE DI UN NUOVO GENE ONCOSOPPRESSORE PER LE LESIONI FOLLICOLARI TIROIDEE NELLA REGIONE MINIMA COMUNE DELETA 7Q21.2. 56
CARATTERIZZAZIONE DEL RUOLO DELL’FZD-1 QUALE GENE ONCOSOPPRESSORE COINVOLTO NEL CARCINOMA FOLLICOLARE TIROIDEO. 54
The use of Laser Capture Microdissection in the identification of new putative oncosoppressor genes in thyroid cancer 49
3,3',5-Triiodo-L-Thyronine (LT3) downregulates the expression of the antiapoptotic factor Galectin-3 in human thyroid cancer cell lines. 45
Frizzled-1 is downregulated in human follicular thyroid cancer cell lines and modulates growth and invasiveness. 44
ANALISI DEI MECCANISMI ATTRAVERSO CUI LA P53 REGOLA LA GALECTINA-3 NEI TESSUTI FETALI UMANI E NEI TUMORI TIROIDEI. 43
ESPRESSIONE GENICA DELLA VIA p53/HGF/c-met/STAT3 NEI FETI CON MALFORMAZIONI DEL SISTEMA NERVOSO. 40
HIPK2 is involved in the overexpression of the anti-apoptotic tumour marker galectin-3 in Papillary Thyroid Cancer 40
IL GENE FZD-1 ? DOWNREGOLATO IN MODO SPECIFICO NEI TUMORI TIROIDEI DI TIPO FOLLICOLARE E MODULA LA CRESCITA E L’INVASIVITA' CELLULARE. 40
Analisi dell'espressione dei fattori di crescita insulino-simili e dei loro mediatori intracellulari nei tumori tiroidei. 40
I CARCINOMI TIROIDEI PAPILLIFERO E FOLLICOLARE MOSTRANO PERDITA DI ETEROZIOGOSI (LOH) IN DUE DISTINTE REGIONI DEL BRACCIO LUNGO DEL CROMOSOMA 7 39
Frizzled-1 (FZD-1) expression is reduced in follicular thyroid cancer specimens and cell lines. 39
Valutazione del ruolo prognostico dell’istologica invasione vascolare nei carcinoma papilliferi della tiroide. 38
EXPRESSION OF P53/HGF/C-MET/STAT3 SIGNAL IN FETUSES WITH MALFORMATION OF NERVOUS SYSTEM. 37
Insulin receptor substrate - 3 (IRS-3) stimulates differentiation of hemopoietic cells 35
GALECTIN-3 EXPRESSION MODULATES CHEMORESISTANCE OF ANAPLASTIC THYROID CARCINOMA CELL LINES 35
Thyroid hormones downregulate the expression of the antiapoptotic factor Galectin-3 via p53 in human thyroid cancer cells. 34
Loss of HIPK-2 and the paradoxical co-expression of wt-p53 and Gal-3 in well-differentiated thyroid tumors 32
P53 requires activation by HIPK2 to repress galectin-3 and induce apoptosis 31
HIPK2 INDUCE APOPTOSI ATTIVANDO LA REPRESSIONE P53-MEDIATA DELLA GALECTINA-3 E AGISCE COME UN POTENZIALE GENE ONCOSOPPRESSORE 30
EFFETTI DELLE MUTAZIONI DI P53 SULL’ESPRESSIONE DELLA GALECTINA-3 IN LINEE CELLULARI DI CARCINOMA TIROIDEO UMANO. 28
LOH analysis at 7q32-34 in Papillary Thyroid Carcinomas reveals a new apoptotic pathway involving HIPK2, p53, and galectin-3 25
L'IGF-1R, L'irs-1e L'IRS- 2 sono maggiormente espressi nei tumori papilliferi della tiroide rispetto a quelli follicolari. 25
Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation 24
Papillary and Follicular Thyroid Carcinomas show LOH in two distinct regions of the long arm of cromosome 7 23
RESTORATION OF FRIZZLED-1 EXPRESSION REDUCES GROWTH AND INVASIVENESS OF HUMAN THYROID FOLLICULAR CANCER CELL LINE. 22
PAPILLARY AND FOLLICULAR THYROID CARCINOMAS SHOW ALLELIC LOSS IN THE SAME CHROMOSOME 7q, BUT IN TWO DIFFERENT GENETIC LOCI. 20
Loss of HIPK-2 expression is responsible for the paradoxical co-expression of the wt-p53 and Galectin-3 in well-differentiated thyroid tumors 18
Overexpression of insulin receptor substrate-3 (IRS-3) stimulates differentiation of 32D cells 13
Totale 2.229
Categoria #
all - tutte 6.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020298 0 0 0 0 0 66 58 41 45 51 32 5
2020/2021149 27 14 8 14 0 8 4 16 11 29 14 4
2021/2022407 1 27 36 8 57 14 7 35 37 40 36 109
2022/2023587 117 66 27 68 71 72 4 27 69 42 24 0
2023/2024163 7 26 8 14 12 22 4 5 0 29 19 17
2024/2025182 23 12 23 20 31 73 0 0 0 0 0 0
Totale 2.229